S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
3 Top-Rated, Oversold Industry Giants
Public Service Announcement: New National Emergency Incoming (Ad)
PayPal Keeps Getting Cheaper; Should You Load Up?
What's Really Behind The FTC's Lawsuit Targeting of Amazon?
The Next Best AI Stock to Watch After Nvidia (Ad)
Delta Hopes to Soar Again with Customer Loyalty Tweaks
Is the Grinch Stealing This Year's Holiday Season Jobs?
The Next Best AI Stock to Watch After Nvidia (Ad)
The Next Stage Of Google’s Rally Just Started
Nike, Amicus Therapeutics rise; Vail Resorts, Hess fall, Friday, 9/29/2023
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
3 Top-Rated, Oversold Industry Giants
Public Service Announcement: New National Emergency Incoming (Ad)
PayPal Keeps Getting Cheaper; Should You Load Up?
What's Really Behind The FTC's Lawsuit Targeting of Amazon?
The Next Best AI Stock to Watch After Nvidia (Ad)
Delta Hopes to Soar Again with Customer Loyalty Tweaks
Is the Grinch Stealing This Year's Holiday Season Jobs?
The Next Best AI Stock to Watch After Nvidia (Ad)
The Next Stage Of Google’s Rally Just Started
Nike, Amicus Therapeutics rise; Vail Resorts, Hess fall, Friday, 9/29/2023
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
3 Top-Rated, Oversold Industry Giants
Public Service Announcement: New National Emergency Incoming (Ad)
PayPal Keeps Getting Cheaper; Should You Load Up?
What's Really Behind The FTC's Lawsuit Targeting of Amazon?
The Next Best AI Stock to Watch After Nvidia (Ad)
Delta Hopes to Soar Again with Customer Loyalty Tweaks
Is the Grinch Stealing This Year's Holiday Season Jobs?
The Next Best AI Stock to Watch After Nvidia (Ad)
The Next Stage Of Google’s Rally Just Started
Nike, Amicus Therapeutics rise; Vail Resorts, Hess fall, Friday, 9/29/2023
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
3 Top-Rated, Oversold Industry Giants
Public Service Announcement: New National Emergency Incoming (Ad)
PayPal Keeps Getting Cheaper; Should You Load Up?
What's Really Behind The FTC's Lawsuit Targeting of Amazon?
The Next Best AI Stock to Watch After Nvidia (Ad)
Delta Hopes to Soar Again with Customer Loyalty Tweaks
Is the Grinch Stealing This Year's Holiday Season Jobs?
The Next Best AI Stock to Watch After Nvidia (Ad)
The Next Stage Of Google’s Rally Just Started
Nike, Amicus Therapeutics rise; Vail Resorts, Hess fall, Friday, 9/29/2023

Inspire Medical Systems (INSP) Stock Forecast, Price & News

$198.44
-1.94 (-0.97%)
(As of 09/29/2023 ET)
Compare
Today's Range
$197.30
$203.28
50-Day Range
$185.07
$291.01
52-Week Range
$159.62
$330.00
Volume
578,151 shs
Average Volume
425,278 shs
Market Capitalization
$5.82 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$345.08

Inspire Medical Systems MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
73.9% Upside
$345.08 Price Target
Short Interest
Healthy
4.02% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.66
Upright™ Environmental Score
News Sentiment
1.01mentions of Inspire Medical Systems in the last 14 days
Based on 8 Articles This Week
Insider Trading
Selling Shares
$822,494 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($1.76) to ($0.45) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.84 out of 5 stars

Medical Sector

64th out of 973 stocks

Surgical & Medical Instruments Industry

11th out of 101 stocks


INSP stock logo

About Inspire Medical Systems (NYSE:INSP) Stock

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

INSP Price History

INSP Stock News Headlines

These cryptos could skyrocket by January
After the massive market collapse and several huge scandals last year, a lot of experts are saying the crypto markets are just one more step away from going to zero. But are they right?
These cryptos could skyrocket by January
After the massive market collapse and several huge scandals last year, a lot of experts are saying the crypto markets are just one more step away from going to zero. But are they right?
InspireSemi Announces Final Closing of Non-Brokered Private Placement
The Latest Analyst Ratings for Inspire Medical Systems
Inspire Medical Systems earnings: here's what Wall Street expects
See More Headlines
Receive INSP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Inspire Medical Systems and its competitors with MarketBeat's FREE daily newsletter.

INSP Company Calendar

Last Earnings
8/01/2023
Today
9/30/2023
Next Earnings (Estimated)
11/07/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Fax
N/A
Employees
755
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$345.08
High Stock Price Forecast
$380.00
Low Stock Price Forecast
$308.00
Forecasted Upside/Downside
+73.9%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
11 Analysts

Profitability

Net Income
$-44,880,000.00
Pretax Margin
-7.66%

Debt

Sales & Book Value

Annual Sales
$526.08 million
Book Value
$17.17 per share

Miscellaneous

Free Float
28,016,000
Market Cap
$5.82 billion
Optionable
Optionable
Beta
1.40
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

  • Mr. Timothy P. HerbertMr. Timothy P. Herbert (Age 60)
    CEO, Pres & Director
    Comp: $1.35M
  • Mr. Richard J. BuchholzMr. Richard J. Buchholz (Age 55)
    Chief Financial Officer
    Comp: $683.2k
  • Mr. Philip J. EbelingMr. Philip J. Ebeling (Age 52)
    Chief Operating Officer
    Comp: $696.13k
  • Mr. John C. RondoniMr. John C. Rondoni (Age 43)
    Chief Technology Officer
    Comp: $576.72k
  • Mr. Randall A. Ban (Age 58)
    Chief Commercial Officer
    Comp: $759.23k
  • Dr. Charisse Y. Sparks FAAOS (Age 60)
    M.D., Chief Medical Officer
    Comp: $21.88k
  • Ms. Ezgi Yagci
    VP of Investor Relations
  • Mr. Bryan K. Phillips (Age 52)
    Sr. VP, Gen. Counsel, Chief Compliance Officer & Corp. Sec.
  • Mr. Martin A. Abrams
    VP of Marketing & Customer Experience
  • Mr. Steven L. JandrichMr. Steven L. Jandrich (Age 56)
    VP of HR













INSP Stock - Frequently Asked Questions

Should I buy or sell Inspire Medical Systems stock right now?

11 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Inspire Medical Systems in the last year. There are currently 11 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" INSP shares.
View INSP analyst ratings
or view top-rated stocks.

What is Inspire Medical Systems' stock price forecast for 2023?

11 equities research analysts have issued 12-month price objectives for Inspire Medical Systems' shares. Their INSP share price forecasts range from $308.00 to $380.00. On average, they expect the company's stock price to reach $345.08 in the next twelve months. This suggests a possible upside of 73.9% from the stock's current price.
View analysts price targets for INSP
or view top-rated stocks among Wall Street analysts.

How have INSP shares performed in 2023?

Inspire Medical Systems' stock was trading at $251.88 on January 1st, 2023. Since then, INSP shares have decreased by 21.2% and is now trading at $198.44.
View the best growth stocks for 2023 here
.

Are investors shorting Inspire Medical Systems?

Inspire Medical Systems saw a increase in short interest during the month of September. As of September 15th, there was short interest totaling 1,180,000 shares, an increase of 14.6% from the August 31st total of 1,030,000 shares. Based on an average daily trading volume, of 512,100 shares, the days-to-cover ratio is currently 2.3 days.
View Inspire Medical Systems' Short Interest
.

When is Inspire Medical Systems' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 7th 2023.
View our INSP earnings forecast
.

How were Inspire Medical Systems' earnings last quarter?

Inspire Medical Systems, Inc. (NYSE:INSP) released its quarterly earnings data on Tuesday, August, 1st. The company reported ($0.41) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.51) by $0.10. The firm earned $151.09 million during the quarter, compared to analysts' expectations of $136.47 million. Inspire Medical Systems had a negative trailing twelve-month return on equity of 8.21% and a negative net margin of 7.81%. The business's revenue for the quarter was up 65.3% on a year-over-year basis. During the same period in the prior year, the company earned ($0.53) EPS.

What guidance has Inspire Medical Systems issued on next quarter's earnings?

Inspire Medical Systems updated its FY 2023 earnings guidance on Tuesday, August, 1st. The company provided EPS guidance of for the period. The company issued revenue guidance of $600.00 million-$610.00 million, compared to the consensus revenue estimate of $589.63 million.

What is Tim Herbert's approval rating as Inspire Medical Systems' CEO?

2 employees have rated Inspire Medical Systems Chief Executive Officer Tim Herbert on Glassdoor.com. Tim Herbert has an approval rating of 100% among the company's employees. This puts Tim Herbert in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Inspire Medical Systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Inspire Medical Systems investors own include Advanced Micro Devices (AMD), NVIDIA (NVDA), Cisco Systems (CSCO), Bank of America (BAC), DocuSign (DOCU), Pfizer (PFE), Block (SQ), Zynga (ZNGA), CrowdStrike (CRWD) and Johnson & Johnson (JNJ).

When did Inspire Medical Systems IPO?

(INSP) raised $75 million in an initial public offering (IPO) on Thursday, May 3rd 2018. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. BofA Merrill Lynch and Goldman Sachs served as the underwriters for the IPO and Guggenheim Securities, Stifel and Wells Fargo Securities were co-managers.

What is Inspire Medical Systems' stock symbol?

Inspire Medical Systems trades on the New York Stock Exchange (NYSE) under the ticker symbol "INSP."

How do I buy shares of Inspire Medical Systems?

Shares of INSP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Inspire Medical Systems' stock price today?

One share of INSP stock can currently be purchased for approximately $198.44.

How much money does Inspire Medical Systems make?

Inspire Medical Systems (NYSE:INSP) has a market capitalization of $5.82 billion and generates $526.08 million in revenue each year. The company earns $-44,880,000.00 in net income (profit) each year or ($1.44) on an earnings per share basis.

How many employees does Inspire Medical Systems have?

The company employs 755 workers across the globe.

How can I contact Inspire Medical Systems?

Inspire Medical Systems' mailing address is 5500 WAYZATA BLVD SUITE 1600, GOLDEN VALLEY MN, 55416. The official website for the company is www.inspiresleep.com. The company can be reached via phone at (844) 672-4357 or via email at inspire@lifesciadvisors.com.

This page (NYSE:INSP) was last updated on 9/30/2023 by MarketBeat.com Staff

My Account -